Christian Marcazzo, vice president/general manager of IDBS discusses how cloud-based solutions can create seamless communication between innovators and CDMOs.
Key insights:
- The forecast for outsourcing cell and gene therapies (CGT) is more than 60% and the CGT CDMO market is expected to grow at 25% annually.
- Cloud-based systems provide an attractive entry point for small biotechs as they don’t require investment in IT infrastructure yet still provide the ability to scale up.
- Cloud solutions enable side-by-side comparison across sites, providing a holistic view that supports more fluid collaboration across teams.
Through cloud-based solutions, outsourcing/partnership models can be designed to share scientific and process information by merging collective expertise from both the innovator and the CDMO.